The cleanroom POD system will be used for the manufacture of virally-modified cell therapy products in the US
POD cleanroom units can provide extra capacity with a fast turnaround
G-CON of Texas, has delivered a custom built cleanroom POD system to Lonza for the manufacture of virally-modified cell therapy products in Houston, US.
Lonza, a global leader in viral gene and cell therapy manufacturing, required cleanroom capacity on an accelerated timeframe to be able to meet rising customer demand.
The customised POD system provides integrated gown in and gown out areas, cleanroom space, dedicated exits for personnel and material, a gas fire suppression system, HVAC control system and onboard HVAC, modular wall panels and a NORA floor system.
The POD system provides ISO 6 and ISO 7 areas and a dedicated mechanical space.
Ricardo Jimenez, Lonza’s Site Director for Lonza Houston, explained what set G-CON apart: “G-CON understood our needs to quickly install a comprehensive solution that allowed us the flexibility we needed for our existing clinical manufacturing facility. Their substantial experience with design, engineering, project management, construction and operation of the POD was evident throughout the project from our decision to purchase all the way to delivery and commissioning.”
Maik Jornitz, President and CEO of G-CON Manufacturing said: “We committed to an aggressive timeframe for delivery and installation of the custom-built POD system because we knew of the importance of the timeline for Lonza in this cell therapy application, a major new area of drug development for Lonza as well as G-CON.
"In working with Lonza we gained further understanding of what the cell therapy industry requires in the provision of cleanrooms and found that PODs are uniquely able to fill all of the requirements of that industry while also providing scalability as needed and without interrupting existing operations.”
G-CON’s cleanroom POD portfolio provides a number of dimensions for a variety of uses, from laboratory environments to personalised medicine and production process platforms.
The POD cleanroom units offer scalability, mobility and the possibility of repurposing the PODs once the production process reaches its lifecycle end.